These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31659178)

  • 1. Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.
    Villalba M; Redin E; Exposito F; Pajares MJ; Sainz C; Hervas D; Guruceaga E; Diaz-Lagares A; Cirauqui C; Redrado M; Valencia K; de Andrea C; Jantus-Lewintre E; Camps C; Lopez-Lopez R; Lahoz A; Montuenga L; Pio R; Sandoval J; Calvo A
    Sci Rep; 2019 Oct; 9(1):15400. PubMed ID: 31659178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients.
    Villalba M; Diaz-Lagares A; Redrado M; de Aberasturi AL; Segura V; Bodegas ME; Pajares MJ; Pio R; Freire J; Gomez-Roman J; Montuenga LM; Esteller M; Sandoval J; Calvo A
    Oncotarget; 2016 Apr; 7(16):22752-69. PubMed ID: 26989022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.
    Exposito F; Villalba M; Redrado M; de Aberasturi AL; Cirauqui C; Redin E; Guruceaga E; de Andrea C; Vicent S; Ajona D; Montuenga LM; Pio R; Calvo A
    Cancer Lett; 2019 Jul; 453():21-33. PubMed ID: 30905815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology.
    Larzabal L; Nguewa PA; Pio R; Blanco D; Sanchez B; Rodríguez MJ; Pajares MJ; Catena R; Montuenga LM; Calvo A
    Br J Cancer; 2011 Nov; 105(10):1608-14. PubMed ID: 22067904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The upregulation of TMPRSS4, partly ascribed to the downregulation of miR‑125a‑5p, promotes the growth of human lung adenocarcinoma via the NF‑κB signaling pathway.
    Fan X; Liang Y; Liu Y; Bai Y; Yang C; Xu S
    Int J Oncol; 2018 Jul; 53(1):148-158. PubMed ID: 29750426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
    Nokin MJ; Darbo E; Travert C; Drogat B; Lacouture A; San José S; Cabrera N; Turcq B; Prouzet-Mauleon V; Falcone M; Villanueva A; Wang H; Herfs M; Mosteiro M; Jänne PA; Pujol JL; Maraver A; Barbacid M; Nadal E; Santamaría D; Ambrogio C
    JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia.
    Nguyen TH; Weber W; Havari E; Connors T; Bagley RG; McLaren R; Nambiar PR; Madden SL; Teicher BA; Roberts B; Kaplan J; Shankara S
    Int J Oncol; 2012 Sep; 41(3):829-38. PubMed ID: 22692880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma.
    Hamamoto J; Soejima K; Naoki K; Yasuda H; Hayashi Y; Yoda S; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Arai D; Ishioka K; Ohgino K; Betsuyaku T
    Cancer Sci; 2015 Jan; 106(1):34-42. PubMed ID: 25414083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMPRSS4 Expression as a Marker of Recurrence in Patients with Lung Cancer.
    Chikaishi Y; Uramoto H; Koyanagi Y; Yamada S; Yano S; Tanaka F
    Anticancer Res; 2016 Jan; 36(1):121-7. PubMed ID: 26722035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
    Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
    J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.
    Ambrogio C; Gómez-López G; Falcone M; Vidal A; Nadal E; Crosetto N; Blasco RB; Fernández-Marcos PJ; Sánchez-Céspedes M; Ren X; Wang Z; Ding K; Hidalgo M; Serrano M; Villanueva A; Santamaría D; Barbacid M
    Nat Med; 2016 Mar; 22(3):270-7. PubMed ID: 26855149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.
    Chou ST; Peng HY; Mo KC; Hsu YM; Wu GH; Hsiao JR; Lin SF; Wang HD; Shiah SG
    J Exp Clin Cancer Res; 2019 Jun; 38(1):281. PubMed ID: 31253192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
    Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
    Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of t-DARPP Expression Alteration in Association with DDR1 Expression in Non-Small Cell Lung Cancer.
    Damavandi Z; Riahi P; Majidizadeh T; Houshmand M
    Iran Biomed J; 2024 Jan; 28(1):23-30. PubMed ID: 38308500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
    de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
    Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines.
    Azizi R; Salemi Z; Fallahian F; Aghaei M
    J Cell Physiol; 2019 Nov; 234(11):19539-19552. PubMed ID: 30963567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
    Yang SH; Baek HA; Lee HJ; Park HS; Jang KY; Kang MJ; Lee DG; Lee YC; Moon WS; Chung MJ
    Oncol Rep; 2010 Aug; 24(2):311-9. PubMed ID: 20596615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier.
    Bhasin MK; Ndebele K; Bucur O; Yee EU; Otu HH; Plati J; Bullock A; Gu X; Castan E; Zhang P; Najarian R; Muraru MS; Miksad R; Khosravi-Far R; Libermann TA
    Oncotarget; 2016 Apr; 7(17):23263-81. PubMed ID: 26993610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment.
    Assani G; Segbo J; Yu X; Yessoufou A; Xiong Y; Zhou F; Zhou Y
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3679-3687. PubMed ID: 31870109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.